On cholesterol levels and statins in cognitive decline and Alzheimer disease: progress and setbacks

Document Type

Article

Medical Subject Headings

Alzheimer Disease (blood, drug therapy, epidemiology); Arizona (epidemiology); Cholesterol (blood); Cognition Disorders (blood, drug therapy, epidemiology); Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use); Risk Factors

Publication Date

10-1-2009

Publication Title

Alzheimer disease and associated disorders

E-ISSN

1546-4156

Volume

23

Issue

4

First Page

303

Last Page

5

PubMed ID

19935144

Digital Object Identifier (DOI)

10.1097/WAD.0b013e3181a80242

This document is currently not available here.

Share

COinS